{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:10:21Z","timestamp":1783469421502,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.blre.2008.11.001","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T09:41:11Z","timestamp":1231494071000},"page":"143-147","source":"Crossref","is-referenced-by-count":27,"title":["Assessment and management of high-risk pregnancies in women with thrombophilia"],"prefix":"10.1016","volume":"23","author":[{"given":"Galit","family":"Sarig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Vidergor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2008.11.001_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0268-960X(97)90013-8","article-title":"Thrombophilia and fetal loss","volume":"11","author":"Brenner","year":"1997","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2008.11.001_bib2","series-title":"Women\u2019s issues in thrombosis and hemostasis","first-page":"151","article-title":"Haemostasis in normal pregnancy","author":"Bremme","year":"2002"},{"key":"10.1016\/j.blre.2008.11.001_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(06)69204-0","article-title":"Recurrent miscarriage","volume":"368","author":"Rai","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2008.11.001_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM199901073400102","article-title":"Increased frequency of genetic thrombophilia in women with complications of pregnancy","volume":"340","author":"Kupferminc","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.blre.2008.11.001_bib5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0015-0282(01)02971-5","article-title":"Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage","volume":"77","author":"Sarig","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.blre.2008.11.001_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1650282","article-title":"The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women","volume":"75","author":"Sanson","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2008.11.001_bib7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7326\/0003-4819-130-9-199905040-00013","article-title":"Increased risk for fetal loss in carriers of the factor V Leiden mutation","volume":"130","author":"Meinardi","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2008.11.001_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2008.11.001_bib9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1182\/blood.V80.4.975.975","article-title":"Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study","volume":"80","author":"Ginsberg","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.blre.2008.11.001_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1191\/0961203302lu266oa","article-title":"Biology and pathology of the placenta in relation to antiphospholipid antibody-associated pregnancy failure","volume":"11","author":"Sebire","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.blre.2008.11.001_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001703-199712000-00010","article-title":"Obstetric complications of antiphospholipid antibodies","volume":"9","author":"Rai","year":"1997","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.blre.2008.11.001_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1160\/TH07-05-0373","article-title":"Thrombophilias and adverse pregnancy outcome - A confounded problem!","volume":"99","author":"Kist","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2008.11.001_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","article-title":"Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin","volume":"83","author":"Brenner","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2008.11.001_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1538-7836.2003.00066.x","article-title":"Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia","volume":"1","author":"Carp","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2008.11.001_bib15","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2008.11.001_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","article-title":"LIVE-ENOX investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVEENOX study","volume":"3","author":"Brenner","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2008.11.001_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2008.11.001_bib18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJM200010053431405","article-title":"Mutations in coagulation factors in women with unexplained late fetal loss","volume":"343","author":"Martinelli","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.blre.2008.11.001_bib19","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.blre.2008.11.001_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1160\/TH06-10-0606","article-title":"The management of thrombosis in pregnancy: role of low-molecular-weight heparin","volume":"97","author":"Kher","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2008.11.001_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/asheducation-2007.1.143","article-title":"Management of pregnant women with thrombophilia or a history of venous thromboembolism","author":"Bates","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2008.11.001_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V79.1.1.1","article-title":"Low molecular weight heparin","volume":"79","author":"Hirsh","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.blre.2008.11.001_bib23","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1160\/TH05-03-0212","article-title":"Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss","volume":"94","author":"Sarig","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2008.11.001_bib24","first-page":"207","article-title":"Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties","volume":"91","author":"Vignoli","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2008.11.001_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2008.11.001_bib26","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective of enoxaparin safety in 624 pregnancies","volume":"108","author":"Lepercq","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.blre.2008.11.001_bib27","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low molecular weight heparin in pregnancy: a systemic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2008.11.001_bib28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fertnstert.2005.03.048","article-title":"LIVE-ENOX investigators. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the LIVE-ENOX study","volume":"84","author":"Brenner","year":"2005","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.blre.2008.11.001_bib29","first-page":"799","article-title":"College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban","volume":"122","author":"Laposata","year":"1998","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.blre.2008.11.001_bib30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM199709043371001","article-title":"Low-molecular-weight heparin in the treatment of patients with venous thromboembolism","volume":"337","author":"The Columbus Investigators","year":"1997","journal-title":"New Engl J Med"},{"key":"10.1016\/j.blre.2008.11.001_bib31","first-page":"1307","article-title":"A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy","volume":"101","author":"Sephton","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.blre.2008.11.001_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1538-7933.2004.00648.x","article-title":"Is laboratory monitoring of low-molecular-weight heparin therapy necessary? No","volume":"2","author":"Bounameaux","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2008.11.001_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/14767050500275796","article-title":"Prophylactic dosing adjustment in pregnancy based upon measurements of anti-factor Xa levels","volume":"18","author":"Gyamfi","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.blre.2008.11.001_bib34","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/AOG.0b013e31818638dc","article-title":"Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis","volume":"112","author":"Fox","year":"2008","journal-title":"Obstet Gynecol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X08000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X08000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T14:11:45Z","timestamp":1589465505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X08000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0268960X08000829"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2008.11.001","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}